KARADENİZ, M. Et Al. 2023. Hypophosphatemia related to the use of ibrutinib. Journal of Oncology Pharmacy Practice .

KARADENİZ, M., ÇINAR, O. E., Erdogdu, B., MALKAN, Ü. Y., GÖKER, H., & ÖZCEBE, O. İ., (2023). Hypophosphatemia related to the use of ibrutinib. Journal of Oncology Pharmacy Practice .

KARADENİZ, MİNE Et Al. "Hypophosphatemia related to the use of ibrutinib," Journal of Oncology Pharmacy Practice , 2023

KARADENİZ, MİNE Et Al. "Hypophosphatemia related to the use of ibrutinib." Journal of Oncology Pharmacy Practice , 2023

KARADENİZ, M. Et Al. (2023) . "Hypophosphatemia related to the use of ibrutinib." Journal of Oncology Pharmacy Practice .

@article{article, author={MİNE KARADENİZ Et Al. }, title={Hypophosphatemia related to the use of ibrutinib}, journal={Journal of Oncology Pharmacy Practice}, year=2023}